Crisantaspase Recombinant (Rylaze): CADTH Reimbursement Review [Internet]

Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Jul. Report No.: PC0301CL.
CADTH Reimbursement Reviews and Recommendations.
No abstract available

Publication types

  • Review